Page last updated: 2024-08-23

paclitaxel and Central Nervous System Neoplasm

paclitaxel has been researched along with Central Nervous System Neoplasm in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiri-Kordestani, L; Liewehr, DJ; Lin, NU; Palmieri, D; Steeg, PS1
Awada, A; Bachelot, T; Badwe, RA; Bondarenko, I; Bose, R; Bryce, R; Carey, LA; Colomer, R; Demetriou, G; Deo, S; Goswami, C; Inoue, K; Kim, SB; Lee, SC; Mehta, AO; Wong, A; Xu, F; Yao, B1
Hide, M; Hori, I; Kamegashira, A; Madokoro, N; Mihara, S; Noda, H; Shindo, H; Takahagi, S1
Anelli, V; Bassi, R; Brioschi, L; Campanella, R; Caroli, M; De Zen, F; Gaini, SM; Giussani, P; Riboni, L; Riccitelli, E; Viani, P1
Abali, H; Celik, I1
Brem, H; Dang, W; Li, KW; Tihan, T; Troiano, G; Tyler, BM; Walter, KA1
Burstein, HJ; Klein, P; Lieberman, G; Slamon, DJ; Winer, EP1
Banik, NL; Karmakar, S; Ray, SK1
Brown, WS; Cain, JM; Figge, DC; Greer, BE; Seewaldt, VL; Tamimi, HK1
DeAngelis, LM; Freilich, RJ; Seidman, AD1
Holm, B; Jensen, PB; Sehested, M1

Reviews

1 review(s) available for paclitaxel and Central Nervous System Neoplasm

ArticleYear
CNS metastases in breast cancer: old challenge, new frontiers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-01, Volume: 19, Issue:23

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Central Nervous System Neoplasms; Clinical Trials as Topic; Female; Humans; Neoplasm Recurrence, Local; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Trastuzumab

2013

Trials

3 trial(s) available for paclitaxel and Central Nervous System Neoplasm

ArticleYear
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
    JAMA oncology, 2016, Dec-01, Volume: 2, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Paclitaxel; Quinolines; Receptor, ErbB-2; Trastuzumab

2016
Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Gene Amplification; Humans; In Situ Hybridization, Fluorescence; Paclitaxel; Prevalence; Receptor, ErbB-2; Survival Rate; Time Factors; Trastuzumab; Vinblastine; Vinorelbine

2005
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel.
    Cancer, 1995, Jul-15, Volume: 76, Issue:2

    Topics: Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Female; Humans; Neoplasm Metastasis; Paclitaxel

1995

Other Studies

7 other study(ies) available for paclitaxel and Central Nervous System Neoplasm

ArticleYear
Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
    The Journal of dermatology, 2009, Volume: 36, Issue:8

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Genital Neoplasms, Male; Humans; Male; Paclitaxel; Paget Disease, Extramammary; Skin; Skin Neoplasms; Trastuzumab

2009
Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.
    Cancer investigation, 2012, Volume: 30, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Central Nervous System Neoplasms; Ceramides; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Glucosyltransferases; Humans; Paclitaxel; Temozolomide

2012
High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Central Nervous System Neoplasms; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Taxoids

2002
Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Aug-15, Volume: 9, Issue:9

    Topics: Animals; Biocompatible Materials; Blood-Brain Barrier; Cell Line, Tumor; Central Nervous System Neoplasms; Chromatography, High Pressure Liquid; Drug Delivery Systems; Glioma; Inflammation; Male; Microspheres; Paclitaxel; Proportional Hazards Models; Rats; Rats, Inbred F344; Time Factors

2003
Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice.
    Cancer, 2008, Feb-01, Volume: 112, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Differentiation; Cell Line, Tumor; Central Nervous System Neoplasms; Cysteine Endopeptidases; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Paclitaxel; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Telomerase; Tretinoin; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2008
Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancy.
    Gynecologic oncology, 1994, Volume: 55, Issue:3 Pt 1

    Topics: Central Nervous System Neoplasms; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Recurrence; Remission Induction

1994
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3

    Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship

1996